These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6528088)

  • 1. Molecular and cellular mechanisms underlying ineffective cancer chemotherapy.
    Rajewsky MF; Huh N
    Recent Results Cancer Res; 1984; 96():18-29. PubMed ID: 6528088
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the effect of antifolics in mouse leukemia.
    Motycka K
    Natl Cancer Inst Monogr; 1971 Dec; 34():167-77. PubMed ID: 4110901
    [No Abstract]   [Full Text] [Related]  

  • 3. Intensive cytotoxic chemotherapy.
    Bagshawe KD
    J R Coll Physicians Lond; 1971 Jan; 5(2):157-66. PubMed ID: 4131399
    [No Abstract]   [Full Text] [Related]  

  • 4. Overview of chemotherapy of cancer of the larynx.
    Nahum AM
    Can J Otolaryngol; 1975; 4(1):4-11. PubMed ID: 1131724
    [No Abstract]   [Full Text] [Related]  

  • 5. Is there life after methotrexate?
    Bertino JR
    Cancer Invest; 2002; 20(4):593-4. PubMed ID: 12094553
    [No Abstract]   [Full Text] [Related]  

  • 6. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.
    Jolivet J; Chabner BA
    J Clin Invest; 1983 Sep; 72(3):773-8. PubMed ID: 6193143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of ionising radiation and cancer chemotherapy agents.
    Nias AH
    Biochem Pharmacol; 1976 Oct; 25(19):2117-24. PubMed ID: 788720
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular mechanisms of cellular resistance to folate analogs.
    Grzelakowska-Sztabert B
    Prog Clin Biol Res; 1983; 132C():213-22. PubMed ID: 6634773
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical pharmacology of antineoplastic agents (first of two parts).
    Chabner BA; Myers CE; Coleman CN; Johns DG
    N Engl J Med; 1975 May; 292(21):1107-13. PubMed ID: 124015
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular mechanisms of resistance to antifolates, a review.
    Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR
    Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene amplification and drug resistance in mammalian cells.
    Schimke RT; Brown PC; Kaufman RJ
    Natl Cancer Inst Monogr; 1982; 60():79-86. PubMed ID: 7121575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in the DNA repair pathway as a potential determinant of response to platinum-based chemotherapy in breast cancer.
    Beheshti F; Hassanian SM; Khazaei M; Hosseini M; ShahidSales S; Hasanzadeh M; Maftouh M; Ferns GA; Avan A
    J Cell Physiol; 2018 Apr; 233(4):2752-2758. PubMed ID: 28696006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of drug resistance in human leukemia.
    Bertino JR; Srimatkandada S; Carman MD; Mini E; Jastreboff M; Moroson BA; Dube SK
    Haematol Blood Transfus; 1985; 29():90-5. PubMed ID: 4029741
    [No Abstract]   [Full Text] [Related]  

  • 14. Resveratrol mediated cell death in cigarette smoke transformed breast epithelial cells is through induction of p21Waf1/Cip1 and inhibition of long patch base excision repair pathway.
    Mohapatra P; Satapathy SR; Das D; Siddharth S; Choudhuri T; Kundu CN
    Toxicol Appl Pharmacol; 2014 Mar; 275(3):221-31. PubMed ID: 24467951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Natural anti-mutagenic and anti-carcinogenic substances].
    Rahden-StaroĊ„ I
    Postepy Biochem; 1990; 36(3-4):16-22. PubMed ID: 2095553
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antimetabolites in the therapy of human acute leukemia. Mechanism of action and factors conditioning the cellular response to the drugs. 3. Cellular kinetics and chemotherapy].
    Grignani F; Martelli M; Tonato M
    Clin Ter; 1974 Mar; 69(3):263-79. PubMed ID: 4846658
    [No Abstract]   [Full Text] [Related]  

  • 17. Folate antagonists: toward improving the therapeutic index and development of new analogs.
    Bertino JR
    J Clin Pharmacol; 1990 Apr; 30(4):291-5. PubMed ID: 2140369
    [No Abstract]   [Full Text] [Related]  

  • 18. [New approach to the treatment of malignant diseases using cytostatic drugs. (Comprehensive review)].
    Klener P
    Vnitr Lek; 1974 May; 20(5):476-84. PubMed ID: 4602412
    [No Abstract]   [Full Text] [Related]  

  • 19. Translational regulation of the synthesis of dihydrofolate reductase.
    Ercikan E; Banerjee D; Waltham M; Schnieders B; Scotto KW; Bertino JR
    Adv Exp Med Biol; 1993; 338():537-40. PubMed ID: 8304175
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential alterations of dihydrofolate reductase gene in human leukemia cell lines made resistant to various folate analogues.
    Miyachi H; Takemura Y; Kobayashi H; Ando K; Ando Y
    Jpn J Cancer Res; 1993 Jan; 84(1):9-12. PubMed ID: 8449831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.